2021
DOI: 10.1021/acs.accounts.0c00830
|View full text |Cite
|
Sign up to set email alerts
|

Development and Evolution of Energetic Cocrystals

Abstract: Conspectus In spite of the importance of energetic materials to a broad range of military (munitions, missiles) and civilian (mining, space exploration) technologies, the introduction of new chemical entities in the field occurs at a very slow pace. This situation is understandable considering the stringent requirements for cost and safety that must be met for new chemical entities to be fielded. If existing manufacturing infrastructure could be leveraged, then this would offer a fundamental shift in the disco… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
79
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 98 publications
(79 citation statements)
references
References 59 publications
0
79
0
Order By: Relevance
“…The pre-exponential factor is estimated by using the CE by a single heating rate method in the succeeding correlation eqn (20):…”
Section: Kinetic Modelingmentioning
confidence: 99%
See 1 more Smart Citation
“…The pre-exponential factor is estimated by using the CE by a single heating rate method in the succeeding correlation eqn (20):…”
Section: Kinetic Modelingmentioning
confidence: 99%
“…[17][18][19] Several energetic co-crystals with interesting features have been developed so far and the topic continues to attract current/future and increasingly intense international discussion to fulll the requirement of the next generation of EMs. [20][21][22] As one of the most interesting propellant oxidizer and explosive ingredient, AN displays prominent characteristics such a positive oxygen balance, low cost, availability, and 100% of gaseous decomposition products. 23 Nonetheless, AN exhibits unneglectable shortcomings such as low energy rate, poor ignitability, lower burning rate, high hygroscopicity, and an ambient temperature polymorphic solid-solid phase transition, acknowledged as one of the foremost reason for damaging and caking of AN-based energetic formulations, which inhibits its extensive employments, particularly as solid-propellant ingredient.…”
Section: Introductionmentioning
confidence: 99%
“…Multi-component organic crystals have been known of since at least 1844, when Wöhler synthesized quinhydrone from p -quinone and hydroquinone [ 1 ]. Interest in these materials was renewed in recent years, after it was widely recognized that the incorporation of two or more different molecules in the same crystal could open a variety of opportunities for product innovation [ 2 ] and patenting [ 3 ] in industrial sectors such as dyes [ 4 ], agrochemicals [ 5 ], optics [ 6 , 7 ], energetic materials [ 8 , 9 , 10 ], and pharmaceuticals [ 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 ]. Thus, for example, energetic materials made of bi-component crystals with better stability than their individual precursors have been reported [ 8 , 9 , 10 ], and medicines based on bi-component crystals (API-CF) consisting of an active pharmaceutical ingredient (API) and a pharmaceutically acceptable co-former (CF) or two APIs (API–API) have been marketed or are in clinical development [ 19 , 20 ].…”
Section: Introductionmentioning
confidence: 99%
“…Interest in these materials was renewed in recent years, after it was widely recognized that the incorporation of two or more different molecules in the same crystal could open a variety of opportunities for product innovation [ 2 ] and patenting [ 3 ] in industrial sectors such as dyes [ 4 ], agrochemicals [ 5 ], optics [ 6 , 7 ], energetic materials [ 8 , 9 , 10 ], and pharmaceuticals [ 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 ]. Thus, for example, energetic materials made of bi-component crystals with better stability than their individual precursors have been reported [ 8 , 9 , 10 ], and medicines based on bi-component crystals (API-CF) consisting of an active pharmaceutical ingredient (API) and a pharmaceutically acceptable co-former (CF) or two APIs (API–API) have been marketed or are in clinical development [ 19 , 20 ]. In the pharmaceutical area, where the main driving force for research on multi-component crystals currently resides, the goal is typically the improvement and modulation of properties that need to be strictly controlled to warrant the optimal and reproducible performance of a drug (e.g., chemical and physical stability, tabletability, hygroscopicity, solubility, dissolution rate, bioavailability) [ 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 ], or the achievement of multimodal therapy [ 21 , 22 ].…”
Section: Introductionmentioning
confidence: 99%
“…[15] The dense packing is primarily due to diverse coordination modes between Tz and metals. [16] Interestingly, the densely-packed structures are desirable in energetic application, [17][18][19] where the arrangement of nitrogen-rich, energetic molecules like Tz plays a crucial role in modulating the explosive and safety properties (e. g. detonation performance and sensitivity). [20][21][22] Such metal-organic hybrid systems have unique advantages over traditional energetic materials, such as trinitrotoluene (TNT), cyclotrimethylene trinitramine (RDX), and cyclotetramethylene tetranitramine (HMX) as shown in Figure 1a.…”
Section: Introductionmentioning
confidence: 99%